Program report describes consultative pharmacogenetics integration in pediatric care, highlighting improved medication safety and targeted therapy.
Pharmacogenetics (PGx) may identify inter-individual variability influencing drug response, efficacy, and the occurrence of adverse drug events and is a cornerstone of precision medicine. Despite these advantages, clinical integration of PGx faces challenges stemming from a lack of awareness and guidance. To address this, we introduce the establishment of a consultative PGx program within the Division of Clinical Pharmacology & Toxicology at The Hospital for Sick Children (SickKids). The clinic advises healthcare professionals on how to integrate PGx data into their daily clinical practice, thus increasing medication safety.
No takes yet. Share an insight, caveat, or question.
Cohn et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: